Strategic Acquisition Zipdrug was acquired by IngenioRx in 2020 and remains integrated with IngenioRx services for Medicare, Medicaid, and Commercial members. This presents a sales opportunity to align with IngenioRx’s PBM and payor networks, highlighting Zipdrug’s turnkey pharmacy delivery and concierge services as a value-add within the IngenioRx ecosystem.

Payor Partnership The company contracts with health plans to connect members with top-performing pharmacies that offer clinical and concierge services, including doorstep delivery. Potential sales angles include expanding network access, value-based pricing for improved outcomes, and showcasing cost savings for payers through optimized pharmacy benefits.

Small Team, Niche Focus Zipdrug operates with a lean team (2-10 employees) and specializes in data-driven pharmacy delivery within hospital and health care settings. This signals an opportunity to offer scalable, plug-and-play solutions or white-label services to larger health systems or PBMs seeking rapid deployment with lower operational overhead.

Market Positioning As a recognized pioneer in prescription delivery and a recipient of early innovation accolades, Zipdrug’s market history demonstrates credibility with investors and partners. Leverage this credibility to engage health plans and providers seeking proven, outcomes-oriented prescription delivery programs.

Growth Trajectory & Funding With funding over 13 million and a history of financing rounds, Zipdrug has demonstrated investor confidence and growth potential. This can be leveraged to explore co-development opportunities, joint go-to-market efforts with PBMs, and expansion into additional markets or service lines that amplify cost savings for payers.